UnknownPhase 2NCT00678145
Mechanisms of Hypoglycemia Associated Autonomic Failure
Studying Pure autonomic failure
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Albert Einstein College of Medicine
- Principal Investigator
- Meredith Hawkins, M.D., M.S., PT, DPTAlbert Einstein College of Medicine
- Intervention
- naloxone(drug)
- Enrollment
- 116 target
- Eligibility
- 21-60 years · All sexes
- Timeline
- 2008 – 2022
Study locations (1)
- Albert Einstein College of Medicine / General Clinical Research Center, The Bronx, New York, United States
Collaborators
National Institutes of Health (NIH) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00678145 on ClinicalTrials.govOther trials for Pure autonomic failure
Additional recruiting or active studies for the same condition.